Skip to main content

Whole-Exome Sequencing Study Identifies Four Novel Gene Loci Associated with Diabetic Kidney Disease

Manuscript ID: 13296

Submitting Author
Kelly, Tanika
Submitting Author's Email
tkelly@tulane.edu
Authors
Yang Pan1†*, Xiao Sun1†, Xuenan Mi1†, Zhijie Huang1†, Yenchih Hsu2, James E. Hixson3, Donna Munzy4, Ginger Metcalf4, Nora Franceschini5, Adrienne Tin6, Anna Köttgen7,8, Michael Francis9, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Kidney Function Working Group, Jennifer A Brody10, Bryan Kestenbaum11, Colleen M. Sitlani10, Josyf C. Mychaleckyj12, Holly Kramer13, Leslie A. Lange14, Xiuqing Guo15, Shih-Jen Hwang16,17, Marguerite R. Irvin18, Jennifer A. Smith19, Lisa R. Yanek20, Dhananjay Vaidya20, Yii-Der Ida Chen15, Myriam Fornage3,21, Donald M. Lloyd-Jones22, Lifang Hou22, Rasika A. Mathias20, Braxton D. Mitchell23,24 , Patricia A. Peyser19, Sharon L.R. Kardia19, Donna K. Arnett25, Adolfo Correa6, Laura M. Raffield26, Ramachandran S. Vasan16,27, L. Adrienne Cupple16,17, Daniel Levy16,27,28, Robert Kaplan29, Kari E. North5, Jerome I. Rotter15, Charles Kooperberg30, Alexander P. Reiner30,31, Bruce M. Psaty10,31,32, Russell P. Tracy33, Richard A. Gibbs4, Alanna C. Morrison3, Harold Feldman2, Eric Boerwinkle3,4, Jiang He1‡, Tanika N. Kelly1‡* and the CRIC Study Investigators#
Journal name for most current submission
Hum Mol Genet.
Associated TOPMed paper proposal
Whole-exome sequencing study of diabetic nephropathy among participants of the Chronic Renal Insufficiency and Atherosclerosis Risk in Communities cohorts
This manuscript has been approved by the original paper proposal's Working Group(s) or is "single PI" *
This manuscript has been approved by the original paper proposal's Working Group(s) or is "single PI"
Acknowledgments
I have followed instructions for TOPMed Acknowledgments
I've received approval for all data sets used in this manuscript, including adding new data sets and canceling all unused ones. *
I've received approval for all data sets used in this manuscript, including adding new data sets and canceling all unused ones.
I have followed the Data Use Limitations for each of the data sets used in this manuscript, if applicable. *
Yes
I've included at least 1 co-author from each study used in analysis or the PI declined an offer to have their study represented. *
Yes
I certify that all co-authors have reviewed and approved the manuscript for submission. *
Yes
I've included at least 1 DCC/ACC author, or they declined authorship or deemed acknowledgement sufficient.
I have not
I’ve included at least 1 IRC author, or they declined authorship or deemed acknowledgement sufficient.
I have not
I've included at least 1 author from relevant omics center(s) or they declined authorship or deemed acknowledgement sufficient.
I have not

TOPMed data used in this manuscript

The data set approvals listed here should match the TOPMed data used in this manuscript.

Don't see all the data sets you need? Request more data sets at any time.

Please "cancel" any data set requests that were not used in this manuscript. Note: only the paper proposal submitter or their designated updater can cancel data sets.

Parent Study: Consent Group Review Status Actions
ARIC:DS-CVD-IRB Approved automatically after 2 weeks
ARIC:HMB-IRB Approved automatically after 2 weeks
Amish:HMB-IRB-MDS Approved automatically after 2 weeks
CARDIA:HMB-IRB Approved automatically after 2 weeks
CARDIA:HMB-IRB-NPU Approved automatically after 2 weeks
CHS:DS-CVD-MDS Approved
CHS:DS-CVD-NPU-MDS Approved
CHS:HMB-MDS Approved
CHS:HMB-NPU-MDS Approved
FHS:HMB-IRB-MDS Approved automatically after 2 weeks
FHS:HMB-IRB-NPU-MDS Approved automatically after 2 weeks
GENOA:DS-ASC-RF-NPU Approved
GenSalt:DS-HCR-IRB Approved automatically after 2 weeks
GeneSTAR:DS-CVD-IRB-NPU-MDS Approved
HCHS_SOL:HMB Approved automatically after 2 weeks
HCHS_SOL:HMB-NPU Approved automatically after 2 weeks
HyperGEN:DS-CVD-IRB-RD Approved
HyperGEN:GRU-IRB Approved
JHS:DS-FDO-IRB Approved
JHS:DS-FDO-IRB-NPU Approved
JHS:HMB-IRB Approved
JHS:HMB-IRB-NPU Approved
MESA:HMB Approved
MESA:HMB-NPU Approved
THRV:DS-CVD-IRB-COL-NPU-RD Approved automatically after 2 weeks
WHI:HMB-IRB Approved
WHI:HMB-IRB-NPU Approved